Exane Derivatives’s Corelogic, Inc. CLGX Stock Holding History

Exane Derivatives’s Portfolio CLGX Stock Details CLGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-23	Closed	-$1.82K	–	1092
2021 Q1	$1.82K	Hold	23	–	–	﹤0.01%	687
2020 Q4	$1.78K	Buy	23 +3	+15%	+$225	﹤0.01%	638
2020 Q3	$1.35K	Hold	20	–	–	﹤0.01%	595
2020 Q2	$1.34K	Buy	20 +1	+5%	+$44	﹤0.01%	539
2020 Q1	$580	Hold	19	–	–	﹤0.01%	583
2019 Q4	$852	Sell	19 -2	-10%	-$85	﹤0.01%	556
2019 Q3	$971	Hold	21	–	–	﹤0.01%	541
2019 Q2	$878	Sell	21 -3	-13%	-$122	﹤0.01%	563
2019 Q1	$894	Buy	24 +4	+20%	+$148	﹤0.01%	507
2018 Q4	$668	Hold	20	–	–	﹤0.01%	592
2018 Q3	$1.01K	Sell	20 -203	-91%	-$10.3K	﹤0.01%	545
2018 Q2	$11.7K	Sell	223 -57	-20%	-$2.86K	﹤0.01%	453
2018 Q1	$12.5K	Sell	280 -39	-12%	-$1.79K	﹤0.01%	411
2017 Q4	$14.7K	Sell	319 -99	-24%	-$4.58K	﹤0.01%	386
2017 Q3	$19.3K	Sell	418 -42	-9%	-$1.91K	﹤0.01%	356
2017 Q2	$19.9K	Buy	+460	New	+$19.4K	﹤0.01%	365

Exane Derivatives's CLGX Position: Q2 2021 in Review

Exane Derivatives sold out of Corelogic, Inc. (CLGX) in Q2 2021, closing a stake of 23 shares — an estimated $1.82K sold.

Exane Derivatives first reported a position in CLGX in Q2 2017 and held it in 16 quarters. The position peaked at $19.9K in Q2 2017. 0 funds tracked by Wall St. Rank hold CLGX as of Q2 2021.

Exane Derivatives reported no remaining Corelogic, Inc. position as of Q2 2021 after selling out during the quarter.
Exane Derivatives sold 23 Corelogic, Inc. shares in Q2 2021, an estimated $1.82K.
Exane Derivatives first reported a position in Corelogic, Inc. in Q2 2017 and held it in 16 quarters.
Exane Derivatives's Corelogic, Inc. position peaked at $19.9K in Q2 2017.
0 funds tracked by Wall St. Rank held Corelogic, Inc. as of Q2 2021.

Based on Exane Derivatives's 13F filing for Q2 2021, filed 28 Jul 2021.